Today’s issue of WorkCompRecap features the TDI-DWC Research and Evaluation Group’s recent release of a new report that evaluates the utilization and cost patterns of compounded drugs dispensed in the Texas workers’ compensation system.
According to the group, this report is the first extensive evaluation of compounded drugs’ prevalence, costs, components, and utilization patterns by timing, “N” drug status, network status and geographic area. Key findings included that the number of compounded drugs increased from 18,020 prescriptions in 2010 (1.6% of total pharmacy prescriptions) to 26,380 in 2014 (3.2% of total). Since then, the number of compounds decreased steadily to 20,751 in 2016, while their share of the total remained at 3.2%. Additionally, per-claim cost of compounded drugs increased from $1,993 in 2010 to $5,936 in 2016 (a 198% increase) primarily due to increases in the average cost per compounded drug prescription.
Find out more (including a link to the free report!) by clicking here!